Canandaigua National Corp Baxter International Inc Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Baxter International Inc stock. As of the latest transaction made, Canandaigua National Corp holds 6,315 shares of BAX stock, worth $209,594. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,315

Previous 6,305 0.16%

Holding current value

$209,594

Previous $340,000 5.29%

% of portfolio

0.05%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$49.7 - $57.71 $497 - $577	10 Added 0.16%	6,315 $322,000
Q3 2022 Oct 05, 2022	SELL	$53.86 - $66.8 $1,938 - $2,404	-36 Reduced 0.57%	6,305 $340,000
Q2 2022 Jul 05, 2022	SELL	$63.83 - $80.0 $3,446 - $4,320	-54 Reduced 0.84%	6,341 $407,000
Q1 2022 May 09, 2022	SELL	$76.85 - $89.45 $94,909 - $110,470	-1,235 Reduced 16.19%	6,395 $496,000
Q4 2021 Jan 04, 2022	SELL	$74.57 - $87.19 $29,529 - $34,527	-396 Reduced 4.93%	7,630 $655,000
Q3 2021 Oct 04, 2021	BUY	$73.77 - $83.61 $104,384 - $118,308	1,415 Added 21.4%	8,026 $646,000
Q2 2021 Jul 06, 2021	SELL	$80.5 - $88.01 $11,270 - $12,321	-140 Reduced 2.07%	6,611 $532,000
Q1 2021 Apr 05, 2021	BUY	$76.38 - $86.03 $1,222 - $1,376	16 Added 0.24%	6,751 $569,000
Q4 2020 Feb 11, 2021	SELL	$75.39 - $82.36 $33,020 - $36,073	-438 Reduced 6.11%	6,735 $540,000
Q3 2020 Oct 19, 2020	SELL	$78.33 - $90.73 $18,329 - $21,230	-234 Reduced 3.16%	7,173 $577,000
Q2 2020 Jul 07, 2020	BUY	$78.66 - $94.14 $582,634 - $697,294	7,407 New	7,407 $638,000

Others Institutions Holding BAX

# of Institutions

941

Shares Held

469M

Call Options Held

2.57M

Put Options Held

3.29M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Baxter International Inc Transaction History